SYRE - CIK 0001636282
As of 2026-06-13, Spyre Therapeutics, Inc. (SYRE) has a market capitalization of $7.02 B, making it the #1172 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-13 | $7.02 B |
| 2026-06-12 | $7.02 B |
| 2026-06-11 | $6.52 B |
| 2026-06-10 | $6.53 B |
| 2026-05-29 | $6.27 B |
| 2026-05-28 | $6.30 B |
| 2026-05-26 | $6.45 B |
| 2026-05-25 | $6.43 B |
| 2026-05-24 | $6.43 B |
| 2026-05-22 | $6.43 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-13, Spyre Therapeutics, Inc. (SYRE) has a market capitalization of $7.02 B, making it the #1172 most valuable US-listed company.
Spyre Therapeutics, Inc. is the #1172 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.